A critical advance in cancer study is arising with the use of mini-antibodies to re-engage dysfunctional p53. This crucial cancer inhibitor protein is frequently inactivated in several forms of tumors, leading https://bookmark-dofollow.com/story29824569/vhh-fragments-reactivate-the-p53-protein-the-new-hope-for-malignant-therapy